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The autonomic nervous system plays an important role in physiological and pathological conditions, and has been extensively
evaluated by parametric and non-parametric spectral analysis. To compare the results obtained with fast Fourier transform (FFT)
and the autoregressive (AR) method, we performed a comprehensive comparative study using data from humans and rats during
pharmacological blockade (in rats), a postural test (in humans), and in the hypertensive state (in both humans and rats). Although
postural hypotension in humans induced an increase in normalized low-frequency (LFnu) of systolic blood pressure, the
increase in the ratio was detected only by AR. In rats, AR and FFT analysis did not agree for LFnu and high frequency (HFnu)
under basal conditions and after vagal blockade. The increase in the LF/HF ratio of the pulse interval, induced by methylatropine,
was detected only by FFT. In hypertensive patients, changes in LF and HF for systolic blood pressure were observed only by AR;
FFT was able to detect the reduction in both blood pressure variance and total power. In hypertensive rats, AR presented different
values of variance and total power for systolic blood pressure. Moreover, AR and FFT presented discordant results for LF, LFnu,
HF, LF/HF ratio, and total power for pulse interval. We provide evidence for disagreement in 23% of the indices of blood pressure
and heart rate variability in humans and 67% discordance in rats when these variables are evaluated by AR and FFT under
physiological and pathological conditions. The overall disagreement between AR and FFT in this study was 43%.
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Introduction
The homeostasis of the cardiovascular system is effi-
ciently maintained under control by feedback mechanisms
that act to maintain perfusion pressure to the organs within
a relatively narrow range of variation. The autonomic ner-
vous system plays an important role in blood pressure
regulation, producing adjustments in heart rate and myo-
cardium contractility by altering sympathetic and parasym-
pathetic activities to the heart, and peripheral vascular
resistance and blood volume by constriction of arterial and
venous vessels, respectively (1). These effects occur dur-
ing each cardiac cycle and can be assessed by the varia-
tions in R-R intervals of the electrocardiogram.
In the early 70’s, spectral analysis was applied to
investigate cardiac interval time series (2,3) and to de-
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scribe the rhythmic fluctuations that occur in the band of
the respiratory frequency or high frequencies (Hering
waves) and in lower frequencies (Mayer waves). In 1981,
pharmacological studies showed for the first time that
these variations were associated with the autonomic ner-
vous system and hormonal mechanisms (4), suggesting a
relationship between the spectral components and control
mechanisms of the cardiovascular system. Taken together,
the spectral analysis components facilitated the physical
interpretation of the mechanisms involved in the regulation
of the cardiovascular system. Later, these findings lent
support to the sympathovagal balance hypothesis (5),
whereby the normalized power of the low-frequency (LFnu)
component of heart rate variability was associated with the
sympathetic modulation and the high-frequency (HFnu)
component was associated with parasympathetic modula-
tion. The ratio between these two components established
an index of the autonomic influence to the heart. This
hypothesis was validated during postural changes (or ortho-
static test) that impose perturbation on the cardiovascular
system, revealing potential applications to assess physi-
ological and physiopathological conditions.
The evaluation of autonomic markers on the basis of
spectral analysis can be obtained by parametric (autore-
gressive model, AR, or autoregressive moving average) or
non-parametric (fast Fourier transform, FFT) methods. In
clinical research, both spectral techniques have been ap-
plied for the evaluation of the autonomic indices in myocar-
dial infarction (6), Chagas disease (7) and diabetes (8),
and in the validation of noninvasive blood pressure moni-
toring (9). However, a consensus regarding which is the
most appropriate method for power spectral density inter-
pretation of the cardiovascular system time series has not
been established (10-12). The task force of the European
Society of Cardiology and the North American Society of
Pacing and Electrophysiology established the standardi-
zation of measurement, physiological interpretation, and
clinical use of power spectral analysis (10), and the advan-
tages and disadvantages of both parametric and non-
parametric methods have been described by others
(12).
In view of these considerations, we investigated the
agreement of the AR and FFT methods regarding the
extraction of autonomic markers during 1) postural changes
(tilt test) in healthy volunteers, 2) pharmacological block-
ade of the autonomic nervous system to the heart in
normal control rats, 3) in patients with arterial hyperten-
sion, and 4) in an experimental model of hypertension
(spontaneously hypertensive rats, SHR).
Material and Methods
Animal model and subjects
All experimental procedures followed institutional guide-
lines for the care and use of laboratory animals (rats) and
protocols used here were approved by the Institutional
Review Board of the Medical School, University of São
Paulo, São Paulo, SP, Brazil (humans).
Animals. Ten male normotensive Wistar rats and ten
18-week-old male SHR (Medical School, University of São
Paulo) were fed standard laboratory chow and water ad
libitum while housed (2-3 per cage) in a temperature-
controlled room (22°C) with a 12-12-h dark-light cycle.
Human subjects. Sixteen normotensive volunteers and
8 subjects with mild hypertension and 17 subjects with
severe hypertension were included in the study. Exclusion
criteria were: age of less than 20 or more than 50 years,
diabetes mellitus, cerebrovascular, aortic, or cardiac dis-
ease, smoking habit, and body mass index greater than 35
kg/m2 (Table 1). Hypertensive patients had their medica-
tion regimens changed with the progressive withdrawal of
β-blocker, angiotensin-converting enzyme inhibitors and
central α-blocker over a 2-week period.
Data acquisition and analysis
Experimental model. Under anesthesia with 30 mg/kg
pentobarbitone sodium administered ip, polyethylene cath-
eters (PE-10, 0.28 mm ID, 0.61 mm OD, Biocorp Australia,
Australia) filled with heparin solution were inserted into the
abdominal aorta and inferior vena cava through the left
Table 1. Demographic data of the normotensive and hyperten-
sive subjects studied.
Hypertensive
Normotensive
Mild Severe
Subjects (N) 16 8 17
Gender, M/F 9/7 (56%) 4/4 (50%) 10/7 (59%)
(% male)
Age (years) 25 ± 3 38 ± 8* 52 ± 8*#
Body weight (kg) 66 ± 9 63 ± 5 78 ± 14*#
Height (m) 1.69 ± 0.09 1.61 ± 0.03 1.62 ± 008*
BMI (kg/m2) 22.6 ± 2.9 24.2 ± 1.4 30.2 ± 3.6*#
Ambulatory blood pressure
SBP (mmHg) 115 ± 7 139 ± 16* 168 ± 23*#
MBP (mmHg) 85 ± 8 96 ± 11 126 ± 14*#
DBP (mmHg) 71 ± 9 75 ± 11 105 ± 12*#
Heart rate (bpm) 64 ± 10 71 ± 16 75 ± 12
BMI = body mass index; SBP = systolic blood pressure; MBP =
mean blood pressure; DBP = diastolic blood pressure. *P < 0.05
compared to the normotensive group; #P < 0.05 compared to
mild hypertensive patients (one-way ANOVA).
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femoral artery and vein, respectively. The free ends of the
cannulas were tunneled subcutaneously and exteriorized
in the nape. Blood pressure was measured in conscious
freely moving rats at least 24 h after the surgical proce-
dures by connecting the arterial cannula to a pressure
transducer (Statham P23Dd, Puerto Rico). The blood pres-
sure waveform signal from the transducer was fed to an
amplifier (GPA-4 model 2, Stemtech, Inc., USA), and to a
10-bit analog-to-digital converter (DataQ Instruments, Inc.,
USA) for measurement on a beat-to-beat basis at a sam-
pling rate of 2.0 kHz.
Human subjects. All patients were instructed not to
consume alcohol or caffeine 24 h before the protocol.
During all experimental conditions, blood pressure was
measured with a digital photoplethysmograph, which pro-
vides accurate beat-to-beat systolic and diastolic values
(Finapress, Omeda 2300, Monitoring Systems, USA). This
device uses a photoplethysmographic finger cuff to assess
blood pressure continuously using the vascular unloading
principle. Heart rate was monitored by electrocardiography
(ECG Amplifier, model 13-4615-64, Gould, USA). The
blood pressure waveforms and ECG signals were re-
corded on a beat-to-beat basis (DataQ Instruments) at a
sampling rate of 1.0 kHz.
Signal edition and artifact correction and rejection
Blood pressure waveforms were used to extract beat-
by-beat time series of pulse (PI), and systolic (SBP) and
diastolic (DBP) blood pressure. R-R interval time series
were derived from ECG recordings. The signal pre-pro-
cessing and spectral analysis were conducted by the
same observer. Peak pressure is reported as SBP and the
minimum pressure is reported as DBP. The tagged points
were reviewed and edited if required after visual inspection
with a special signal editor developed for Matlab (MATLAB
6.0, Mathworks, USA) (13). Pulse interval or R-R interval
was calculated as the difference between the beginning
and end points of the cycle (t1-t0).
Blood pressure and pulse/R-R interval variability
Time-domain analysis consisted of calculating mean
PI or R-R intervals and SBP and DBP, followed by their
variability as the variance from their respective time series.
In the frequency-domain analysis, both AR and FFT meth-
ods were used to evaluate blood pressure and pulse
interval and R-R interval variability. Both time- and fre-
quency-domain parameters were determined by software.
The spectral bands for humans (very low-frequency (VLF):
0.0-0.04 Hz; LF: 0.04-0.15 Hz; HF: 0.15-0.4 Hz) and rats
(VLF: 0.0-0.2 Hz; LF: 0.2-0.8 Hz; HF: 0.8-2.8 Hz) were
defined according to literature references (10,14). Spec-
tral power for VLF, LF and HF bands was calculated by
power spectrum density integration within each frequency
band. The power density of each spectral component was
calculated both as absolute values and as normalized
units (nu) (10,15). The power at LF and HF for pulse
interval was normalized and represents the relative value
of each power component in proportion to the total power
minus the VLF component. Data are reported as nu. The
sympathovagal balance was defined by the LF/HF ratio.
The LF component of the R-R and pulse intervals and of
blood pressure variability was considered to be a marker of
efferent sympathetic cardiac and vascular modulation,
respectively, whereas the HF component of the R-R or
pulse interval variability reflects respiratory-driven vagal
modulation to the sinoatrial node (4,16).
For frequency-domain analysis, the whole 10-min time
series of blood pressure and pulse or R-R intervals were
evaluated under basal conditions using parametric and
non-parametric methods, described in detail below.
Autoregressive method. Time series were analyzed
using the Linear Analysis software (LA, version 8.5) (17),
kindly provided by Alberto Porta (Department of Technolo-
gies for Health, Galeazzi Orthopaedic Institute, University
of Milan, Italy). Time series were divided into segments of
300 beats that overlapped by 50%. A linear de-trending
procedure was used, the spectra of each segment were
calculated via the Levinson-Durbin recursion, and the or-
der of the model was chosen according to Akaike’s crite-
rion.
Fast Fourier transform method. The linear trend was
removed before the analysis of power spectral density
obtained by FFT, using Welch’s method. For the signal
obtained in rats, we considered 10 min of data resampled
at 13.8 Hz (first 213 points) and segments of 211 points with
a Hanning window and 50% overlap. For the signal ob-
tained in humans, we considered 10 min of data resampled
at 5.0 Hz (first 211) and segments of 29 points with a
Hanning window and 50% of overlap.
Experimental protocols
Tilt test. An established protocol currently used by
Montano et al. (18) was adopted. During the entire experi-
mental procedure, the normal volunteers (N = 8) were
monitored by blood pressure and ECG measurements.
Head-up tilt testing was performed with the subject in a
non-sedated, post-absorptive state. After heart rate and
blood pressure measurement under basal conditions (10
min), the subject was positioned upright at an angle of
approximately 80 degrees for a maximum of 20 min. If
syncope or pre-syncope with hypotension developed dur-
ing the test, the table was lowered to the supine position.
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Autonomic nervous system blockade. The experimen-
tal protocol was similar to that used in a previous study
performed in our laboratory (19,20). Briefly, a 2-day proto-
col was used for the evaluation of the vagal and sympa-
thetic effects on heart rate of 1 mg/kg methylatropine
(Sigma Chemical Co., USA) and 1 mg/kg propranolol
(Sigma) injected iv. On the first day of the study, heart rate
was recorded for 10 min under basal conditions and after
parasympathetic pharmacological blockade with methylat-
ropine. On the second day of the protocol, the sympathetic
influence on heart rate was evaluated by propranolol injec-
tion followed by methylatropine injection to assess the
double sympathetic and parasympathetic blockade in or-
der to determine the intrinsic heart rate. The effects of
pharmacological blockade on heart rate were recorded for
10 min after both methylatropine and propranolol reached
their maximum effects (~3 min, iv injection).
Statistical analysis
Data are reported as means ± SEM. The agreement of
all time- and frequency-domain data between AR and FFT
was analyzed by two-way analysis of variance (ANOVA)
for repeated measurements followed by the Bonferroni
post hoc test. Demographic data were analyzed by one-
way ANOVA followed by the Bonferroni post hoc test.
Similarly, disagreement between AR and FFT was ana-
lyzed by the percentage of indices that presented statisti-
cal significance for the method factor (F1: AR vs FFT) in the
two-way ANOVA. The level of significance was set at P <
0.05 in all analyses. All procedures were performed with
the SigmaStat statistical software (Systat Software Inc.,
USA).
Results
Autonomic nervous system changes in response to
postural and pharmacological blockade challenges
Normal healthy subjects (N = 8) submitted to postural
challenge (orthostatic tilt test) exhibited hypotension (P =
0.039) accompanied by a significant decrease (P = 0.004)
in R-R interval (Table 2 and Figure 1A). Neither method
showed any significant reduction in R-R interval variance
(P = 0.372). In addition, the FFT technique presented
significantly higher values (P < 0.001) for R-R interval
variance under both basal and tilt conditions compared to
AR. Both the AR and FFT methods demonstrated a signifi-
Table 2. Data obtained for normal volunteers (N = 8) before (basal) and after (tilt) submission to the head-up tilt testing.
AR FFT Statistics
Basal Tilt Basal Tilt F1 F2 F1 x F2
SBP
Mean (mmHg) 129.9 ± 4.0 119.0 ± 4.6 129.9 ± 4.0 119.9 ± 4.6 0.474 0.039$& 0.322
Var (mmHg2) 13.6 ± 3.7 33.1 ± 6.6 22.5 ± 5.1 120.2 ± 53.6 0.087 0.093 0.160
VLF (mmHg2) 1.63 ± - 2.68 ± - 14.2 ± 3.9 65.5 ± 39.4 NA NA NA
LF (mmHg2) 9.3 ± 3.6 19.0 ± 4.1 3.7 ± 0.8 14.7 ± 3.1 0.045* 0.022$& 0.630
HF (mmHg2) 2.2 ± 0.4 8.0 ± 2.7 3.1 ± 0.4 7.8 ± 1.6 0.658 0.029& 0.612
TotP (mmHg2) 13.0 ± 3.7 28.1 ± 5.1 20.3 ± 4.5 89.5 ± 42.6 0.135 0.107 0.236
R-R interval
Mean (ms) 938.2 ± 65.5 736.0 ± 26.0 937.8 ± 65.1 736.0 ± 25.9 0.486 0.004$& 0.413
Var (ms2) 5992 ± 3506 2076 ± 456 7170 ± 3895 4541 ± 775 <0.001*# 0.372 0.089
VLF (ms2) 587 ± - 963 ± 208 1654 ± 837 1606 ± 478 NA NA NA
LF (ms2) 1376 ± 599 922 ± 276 1134 ± 466 926 ± 181 0.360 0.487 0.267
HF (ms2) 2982 ± 1891 535 ± 204 3034 ± 1928 581 ± 228 0.321 0.230 0.941
LFnu (%) 32.6 ± 5.9 49.4 ± 9.0 47.6 ± 13.4 57.0 ± 5.7 0.207 0.225 0.414
HFnu (%) 42.1 ± 6.6 27.0 ± 7.1 55.3 ± 4.9 30.8 ± 6.7 0.055 0.003$& 0.194
LF/HF 1.15 ± 0.41 6.16 ± 2.54 1.01 ± 0.34 2.68 ± 0.62 0.114 0.042& 0.137
TotP (ms2) 4650 ± 2426 1817 ± 429 6021 ± 3220 3188 ± 714 0.066 0.299 0.999
Time domain variance (Var), very low-frequency (VLF), low-frequency (LF) and high-frequency (HF) powers, normalized power of LF
and HF (LFnu and HFnu), sympathovagal balance (LF/HF) and total power (TotP). In the two-way ANOVA, F1 signifies the method
factor (autoregression, AR, or fast Fourier transform, FFT); F2, the autonomic test factor (basal or tilt), and F1 x F2, the interaction
between F1 and F2. NA is non-analyzed data (AR analysis provided only one measure). SBP = systolic blood pressure. $P < 0.05
between basal and tilt conditions for the FFT method. &P < 0.05 between basal and tilt conditions for the AR method. *P < 0.05
between the AR and FFT methods for the basal condition. #P < 0.05 between the AR and FFT methods for the tilt condition.
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cant increase in LF for SBP (P = 0.022), and a decrease in
HFnu for pulse interval (P = 0.003) induced by the tilt test;
however, only the AR method was able to show changes in
HF for SBP (P = 0.029) during the orthostatic tilt test.
Moreover, a significant increase (P = 0.042) in LF/HF ratio
after postural change was observed only with the AR
method.
Pharmacological blockade (Table 3 and Figure 2) was
used to assess the modulation of the autonomic nervous
system produced by sympathetic and parasympathetic
activities to the heart in an experimental model. Vagal
blockade with methylatropine induced a significant reduc-
tion in pulse interval (P < 0.001). However, the blockade of
this cardiac sympathetic activity using propranolol did not
change pulse interval values (Figure 2A) compared to
those of the basal condition. A significant difference in
pulse interval variance was observed under basal condi-
tions (P = 0.030) when AR and FFT were compared. The
absolute values of LF (P = 0.363) and HF (P = 0.150), with
power evaluated by both AR and FFT methods, were not
affected by pharmacological blockade. However, the ab-
solute value of the LF component, estimated by AR, was
lower compared to FFT (P = 0.011) under basal conditions
and after methylatropine blockade. Cardiac sympathetic
blockade with propranolol (Figure 2B) tended to reduce the
LFnu component by FFT, without any change in the AR
method results. Furthermore, HFnu oscillation was signifi-
cantly increased (P < 0.001) by propranolol blockade in
both methods. Parasympathetic blockade with methylatro-
pine (Figure 2C) did not change the LFnu component of
either the AR or FFT method (P = 0.468). The reduction in
HFnu oscillation of PI after parasympathetic blockade with
methylatropine was detected by both the AR and FFT
methods (P < 0.001). In addition, AR and FFT analysis was
not concordant in the values for the LFnu (P < 0.001) and
HFnu (P < 0.001) components under basal and methylat-
Figure 1. Mean pulse interval (PI, Panel A) and LFnu (Panel B) and HFnu (Panel C) oscillations, and LF/HF ratio (Panel D) for PI at
basal condition and after tilt test in normal volunteers. LF = low-frequency; HF = high-frequency; LFnu = normalized power of LF; HFnu
= normalized power of HF; AR = autoregressive method; FFT = fast Fourier transform method. *P ≤ 0.05, compared to respective
basal group. +P ≤ 0.05, FFT compared to AR.
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Table 3. Time- and frequency-domain analysis of pulse interval of normotensive rats (Wistar, N = 8) submitted to pharmacological blockade.
AR FFT Statistics
Basal Methylatropine Propranolol Basal Methylatropine Propranolol F1 F2 F1 x F2
Mean (ms) 169.7±4.9 141.0±4.7 177.4±2.8 169.6±4.8 138.6±2.9 177.3±2.8 0.315 <0.001&+ 0.425
Var (ms2) 29.8±8.2 13.7±2.9 22.1±5.0 102.6±38.0 16.4±2.4 33.9±5.9 0.030# 0.030+ 0.021
VLF (ms2) 16.2±4.4 2.1±0.4 4.3±0.7 71.7±31.7 10.6±3.9 10.8±2.0 0.046# 0.043+ 0.094
LF (ms2) 0.60±0.23 0.22±0.08 0.82±0.23 4.85±1.89 5.40±2.53 1.11±0.30 0.011#$ 0.363 0.192
HF (ms2) 11.13±3.50 7.36±2.21 16.14±4.47 6.16±1.73 2.69±0.84 4.67±1.32 0.012* 0.150 0.042
LFnu (%) 4.61±1.42 1.63±0.23 4.65±0.90 23.76±5.01 25.75±11.45 8.81±3.04 0.006#$ 0.468 0.293
HFnu (%) 86.25±3.44 60.46±4.45 91.74±1.25 36.12±5.01 15.11±5.36 32.98±4.85 <0.001#$* <0.001&+ 0.342
LF/HF 0.061±0.020 0.030±0.003 0.053±0.011 0.724±0.240 1.609±0.269 0.245±0.060 <0.001#$ <0.001+ <0.001
TotP (ms2) 18.46±5.37 12.32±1.31 19.85±5.82 82.93±35.74 18.58±7.24 16.69±3.23 0.053 0.095 0.055
Time domain variance (Var), very low-frequency (VLF), low-frequency (LF) and high-frequency (HF) powers, normalized power of LF and HF
(LFnu and HFnu), sympathovagal balance (LF/HF), and total power (TotP). In the two-way ANOVA, F1 signifies the method factor
(autoregression, AR, or fast Fourier transform, FFT); F2, the pharmacological blockade factor (basal, methylatropine or propranolol), and F1
x F2, the interaction between F1 and F2. #P < 0.05 between the AR and FFT methods for basal. *P < 0.05 between AR and FFT methods for
propranolol. $P < 0.05 between AR and FFT methods for methylatropine. &P < 0.05 between basal vs methylatropine, and methylatropine vs
propranolol for the AR method. +P < 0.05 between basal vs methylatropine, and methylatropine vs propranolol for the FFT method.
Figure 2. Mean pulse interval (PI, Panel A) and LFnu (Panel B) and HFnu (Panel C) oscillations, and LF/HF ratio (Panel D) for PI at
basal condition and after pharmacological blockade of sympathetic (propranolol) and parasympathetic (methylatropine) systems in
rats. LF = low-frequency; HF = high-frequency; LFnu = normalized power of LF; HFnu = normalized power of HF; AR = autoregressive
method; FFT = fast Fourier transform method. *P ≤ 0.05, compared to respective basal condition. +P ≤ 0.05, FFT compared to AR.
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ropine conditions. The LF/HF ratio for pulse interval (Fig-
ure 2D) was unchanged after both sympathetic and para-
sympathetic blockade when evaluated by the AR tech-
nique, but was increased after methylatropine injection
when evaluated by the FFT method (P < 0.001). Further-
more, the AR and FFT techniques showed a disagreement
in the LF/HF ratio of the pulse interval under basal and
methylatropine conditions (P < 0.001).
Autonomic nervous system evaluation in hypertensive
patients and in experimental hypertension
In patients, the autonomic changes commonly associ-
ated with arterial hypertension were used to evaluate the
concordance of the FFT and AR methods (Table 4). As
expected, SBP values increased significantly according to
the severity of arterial hypertension (P < 0.001) compared
to normotensive subjects. R-R interval values under basal
conditions were significantly reduced in the hypertensive
groups (P = 0.038). Both spectral estimation techniques
demonstrated a significant increase in the values of SBP
variance (P < 0.001) according to the severity of hyperten-
sion, and R-R interval variance decreased in both hyper-
tensive (mild and severe) groups (P = 0.004). Neither the
AR nor the FFT method showed any change in the LF (P =
0.688) or HF (P = 0.817) components of SBP in any of the
hypertensive groups. The total power of SBP showed a
nonsignificant increase according to the severity of hyper-
tension only in the FFT method (P = 0.459). However, both
total power (P < 0.001) and variance (P < 0.001) of SBP
were significantly higher in FFT than in the AR method in all
groups evaluated. The LFnu component for the R-R inter-
val showed increasing values according to the severity of
hypertension (P = 0.050) by both methods, whereas the
HFnu component was significantly reduced (P = 0.012).
The increase in the LFnu component was accompanied by
a nonsignificant increase in LF/HF ratio (P = 0.065) in both
methods, and presented a statistical difference between
the AR and FFT methods in normotensive subjects (P =
0.031).
Table 5 shows the time- and frequency-domain data
obtained in an experimental model of hypertension (SHR).
Similar to humans, basal SBP was significantly increased
(P < 0.001) in SHR (N = 8) compared to normotensive
Wistar rats (N = 8). Pulse interval values under basal
Table 4. Time- and frequency-domain analysis of systolic blood pressure (SBP) and R-R interval of normotensive subjects (N = 16), patients
with mild hypertension (N = 8) and patients with severe hypertension (N = 17).
AR FFT Statistics
Normal Mild Severe Normal Mild Severe F1 F2 F1 x F2
SBP
Mean (mmHg) 125.0±2.8 138.6±5.7 175.0±5.8 125.0±2.8 141.7±5.3 175.0±5.8 0.140 <0.001&+ 0.165
Var (mmHg2) 23.2±5.1 30.1±5.6 34.4±9.5 38.4±8.1 69.0±24.8 66.8±15.7 <0.001*$ 0.292 0.205
VLF (mmHg2) 13.8±7.8 29.2±5.0 71.9±31.7 35.8±7.9 53.7±13.8 56.7±14.5 0.040$ 0.791 0.429
LF (mmHg2) 15.1±5.2 5.7±1.1 13.2±3.3 7.4±1.8 11.0±3.1 11.4±1.6 0.525 0.688 0.072
HF (mmHg2) 3.1±0.5 3.2±0.6 2.5±1.2 3.6±0.4 3.3±1.0 3.0±1.1 0.266 0.817 0.886
TotP (mmHg2) 21.8±5.2 27.5±6.8 33.0±9.6 34.6±7.4 51.4±13.8 53.3±14.6 <0.001#*$ 0.459 0.381
R-R interval
Mean (ms) 967±37 884±72 818±30 966±37 883±71 818±30 0.963 0.038&+ 0.999
Var (ms2) 5320±1814 946±194 934±199 6645±2050 1615±350 1489±295 0.004# 0.030+ 0.405
VLF (ms2) 587±- 616±186 537±158 1711±493 608±139 663±152 NA NA NA
LF (ms2) 1259±325 307±92 456±159 1193±266 328±74 351±87 0.429 0.013& 0.741
HF (ms2) 2748±1006 339±105 217±65 2661±1013 391±117 216±61 0.950 0.031& 0.952
LFnu (%) 35.8±6.0 43.5±10.3 62.1±5.1 43.4±7.6 53.0±8.7 56.7±3.6 0.339 0.050 0.251
HFnu (%) 50.5±6.4 39.1±9.2 28.7±4.1 53.8±5.2 47.6±6.3 30.1±5.1 0.126 0.012&+ 0.627
LF/HF 1.37±0.45 2.53±1.15 4.56±1.78 1.13±0.28 1.42±0.42 2.74±0.49 0.084 0.065 0.477
TotP (ms2) 4197±1275 1054±326 920±202 5719±1721 1352±293 1278±276 0.031# 0.023+ 0.180
Time domain variance (Var), very low-frequency (VLF), low-frequency (LF) and high-frequency (HF) powers, normalized power of LF and HF
(LFnu and HFnu), sympathovagal balance (LF/HF), and total power (TotP). In the two-way ANOVA, F1 signifies the method factor
(autoregression, AR, or fast Fourier transform, FFT); F2, the pathological condition factor (normal, mild or severe), and F1 x F2, the interaction
between F1 and F2. NA is non-analyzed data (AR analysis provided only one measure). #P < 0.05 between the AR and FFT methods for
normotensive subjects. *P < 0.05 between the AR and FFT methods for mild hypertensive patients. $P < 0.05 between the AR and FFT
methods for severely hypertensive patients. &P < 0.05 for normal vs mild, and mild vs severe for the AR method. +P < 0.05 for normal vs mild,
and mild vs severe for the FFT method.
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conditions did not differ between groups (P = 0.597) and
were not changed by the method (P = 0.714). High blood
pressure levels were accompanied by significant increases
in SBP (P = 0.004) and pulse interval (P = 0.005) vari-
ances, shown only by the FFT method. Both the AR and
FFT methods demonstrated an increase in the power of LF
oscillation for SBP (P = 0.012) in SHR compared to normo-
tensive Wistar rats. Despite the relative concordance of
the two methods, AR presented different variance values
(P < 0.001) and total power estimation (P < 0.001) for SBP
compared to FFT in the SHR group. Similarly, for pulse
interval analysis, the AR and FFT methods presented a
significant difference in variance (P < 0.001), absolute (P =
0.030) and normalized (P = 0.004) values of the LF compo-
nent, absolute values of HF (P = 0.008), LF/HF ratio (P =
0.010), and total estimation power (P < 0.001).
Discussion
The present study compared the agreement between
the AR and FFT methods under several conditions: a
physiological stimulus, postural changes induced in nor-
mal healthy volunteers or pharmacological blockade in an
experimental model, and under pathological conditions,
i.e., patients with mild and severe hypertension or a ge-
netic experimental model of hypertension (SHR). Despite
specific agreement between parametric and non-paramet-
ric methods in time- and frequency-domain indices, sev-
eral disagreements were detected in the present study.
In the time-domain analysis, the AR and FFT methods
seemed to be concordant, with the exception of differ-
ences detected in the calculation of the time variance of
both PI/R-R interval and SBP under all conditions evalu-
ated. Our data partially agree with the study of Pitzalis et al.
(21) who demonstrated that the time-domain measure-
ments may be considered to be reproducible. Most of the
differences observed between the AR and FFT methods
are related to the frequency-domain analysis. Considering
all the frequency-domain indices evaluated, the present
study found that 43% of the data did not agree. Interest-
ingly, most of the non-concordant time- and frequency-
domain data were related to protocols using experimental
animals (67%); in humans, 23% of non-concordant values
were found in the present study. Moreover, we observed
that the LF component was not concordant between meth-
ods in any of the experimental models, i.e., pharmacologi-
Table 5. Time- and frequency-domain analysis of systolic blood pressure (SBP) and pulse interval (PI) of normotensive (Wistar, N = 8)
and spontaneously hypertensive (SHR, N = 8) rats.
AR FFT Statistics
Wistar SHR Wistar SHR F1 F2 F1 x F2
SBP
Mean (mmHg) 123.4 ± 5.7 188.9 ± 3.6 123.4 ± 5.7 188.9 ± 3.6 0.838 <0.001$& 0.124
Var (mmHg2) 12.1 ± 3.7 34.6 ± 7.5 29.7 ± 14.5 97.0 ± 13.3 <0.001# 0.004$ 0.014
VLF (mmHg2) 10.5 ± 5.7 16.0 ± 0.1 20.5 ± 11.5 50.4 ± 9.4 0.104 0.388 0.370
LF (mmHg2) 2.36 ± 0.90 23.38 ± 7.29 4.89 ± 1.43 17.57 ± 3.10 0.217 0.012$& 0.085
HF (mmHg2) 1.47 ± 0.32 5.09 ± 1.09 1.49 ± 0.39 4.80 ± 0.39 0.117 0.009$& 0.409
TotP (mmHg2) 10.22 ± 3.96 32.60 ± 7.19 26.97 ± 12.74 72.91 ± 10.27 <0.001# 0.007$ 0.018
PI
Mean (ms) 171.5 ± 4.0 168.6 ± 3.4 172.3 ± 4.6 168.6 ± 3.9 0.714 0.597 0.096
Var (ms2) 19.9 ± 6.4 49.6 ± 8.9 45.0 ± 15.7 150.6 ± 29.2 <0.001# 0.005$ 0.026
VLF (ms2) 7.1 ± 1.7 6.7 ± 0.4 29.5 ± 13.7 64.8 ± 17.4 0.001*# 0.054$ 0.041
LF (ms2) 0.80 ± 0.11 3.46 ± 0.52 6.77 ± 4.76 7.70 ± 1.98 0.030# 0.801 0.331
HF (ms2) 12.07 ± 4.57 34.44 ± 7.79 10.77 ± 4.58 29.63 ± 5.56 0.008# 0.023$& 0.126
LFnu (%) 8.25 ± 1.27 9.56 ± 1.68 43.17 ± 17.38 21.10 ± 6.90 0.004*# 0.262 0.846
HFnu (%) 85.57 ± 4.05 70.06 ± 5.07 118.24 ± 50.17 74.29 ± 8.68 0.100 0.338 0.010
LF/HF 0.099 ± 0.023 0.161 ± 0.040 0.393 ± 0.102 0.261 ± 0.049 0.010* 0.325 0.524
TotP (ms2) 18.46 ± 5.37 41.05 ± 6.54 47.79 ± 23.30 104.47 ± 22.46 <0.001# 0.036$ 0.201
Time domain variance (Var), very low-frequency (VLF), low-frequency (LF) and high-frequency (HF) powers, normalized power of LF
and HF (LFnu and HFnu), sympathovagal balance (LF/HF), and total power (TotP). In the two-way ANOVA, F1 signifies the method
factor (autoregression, AR, or fast Fourier transform, FFT); F2, the pathological condition factor (Wistar or SHR), and F1 x F2, the
interaction between F1 and F2. $P < 0.05 between Wistar and SHR groups for the FFT method. &P < 0.05 between Wistar and SHR
groups for the AR method. *P < 0.05 between the AR and FFT methods for Wistar rats. #P < 0.05 between the AR and FFT methods
for SHR.
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cal blockade and genetic hypertension. The AR method
presented 2- and 5-fold lower LFnu values for pulse inter-
val compared to FFT in SHR and normotensive Wistar rats,
respectively. Additionally, we observed significant differ-
ences in the HFnu component of the R-R interval for both
normotensive and hypertensive patients. Indeed, several
studies (22-24) have shown an overestimation of the HF
component by the FFT method. Furthermore, a nonsignifi-
cant increase was observed in the LF/HF ratio for the R-R
interval using the FFT method during the tilt test in normal
healthy volunteers, whereas the AR method showed a
significant increase in sympathovagal balance during the
protocol involving postural changes. In the animal model of
hypertension, we observed higher values of the total power
for the R-R interval when analyzed by the FFT method.
Pichon et al. (24) observed significant differences between
the AR and FFT methods in the total power estimation for
both sitting and standing positions. Moreover, these inves-
tigators showed that the power of the HF component was
greater in the FFT method, suggesting a poor interchange-
ability in the heart rate variability indices in normal volun-
teers when parametric and non-parametric methods were
compared. The disagreement between parametric and
non-parametric methods was not limited to the analysis of
heart rate variability. We were able to detect lower levels of
the LF component for SBP obtained with the FFT method,
compared to AR in normal healthy volunteers. Increased
values of total power estimation for SBP in hypertensive
patients were also observed using the FFT method. The
difference in the total power estimation was consistent with
the data obtained in the experimental model of hyperten-
sion (SHR) for SBP.
With regard to pathological conditions (arterial hyper-
tension), we achieved a total of 33% non-concordant data
for time- and frequency-domain indices. Indeed, Chemla
et al. (25) compared both parametric and non-parametric
methods and showed that FFT overestimated the LF (ms2
and nu) component and LF/HF ratio for the R-R interval in
diabetic patients, while the AR method overestimated the
total power, VLF and HFnu components. These data sug-
gested that parametric and non-parametric methods of
spectral analysis were not comparable in diabetes. In
hypertensive patients, Badilini et al. (26) demonstrated
that, under basal conditions, the FFT method provided a
lower estimation of VLF and total power for the R-R inter-
val, but presented higher values for the LF and HF compo-
nents compared to the AR method. The increase in LFnu
and HFnu values for the R-R interval obtained by the FFT
method compared to AR agrees with our data. We showed
that the FFT method overestimated the normalized values
of the HF component for the R-R interval in both normoten-
sive and severe hypertensive subjects, and overestimated
the total power for SBP only in the normotensive subjects.
The Linear Analysis software used in the present inves-
tigation for the autoregressive technique showed several
undetected or missing VLF, LF and HF values in the spectral
analysis of both blood pressure and PI/R-R interval variabil-
ity in most of the patients and animals studied. On the other
hand, all spectral components obtained with the FFT analy-
sis were detected in animal models and patients. Similarly,
Chemla et al. (25) recently reported that the use of the AR
method resulted in 50% missing values of both LF and HF
components. These investigators showed that changing the
model order of the analysis did not modify the null or missing
data observed with the AR method.
Although a consensus regarding the most appropriate
method for power spectral density estimation of cardiovas-
cular system time series has not been established (10-12),
several advantages and disadvantages regarding para-
metric and non-parametric methods have been described.
The advantages of the non-parametric (FFT) methods are:
the simplicity of the algorithm employed, good reproduc-
ibility, and high processing speed. On the other hand, the
advantages of parametric (AR) methods are: good perfor-
mance in time series with reduced number of points,
smoother spectral components, which can be distinguished
independently of predefined frequency bands, easy post-
processing of the spectrum with an automatic calculation
of low- and high-frequency components, easy identifica-
tion of the central frequency of each component, and an
accurate estimation of power spectrum density even for a
small number of samples in which the signal is supposed to
remain stationary. The basic disadvantage of parametric
methods is the need to verify the suitability of the chosen
order of model. On the other hand, methods based on the
non-parametric (FFT) technique require some experience
in dealing with the non-stationary segments of the time
series and with the overlapping and windowing to filter the
power spectral density. Considering the findings of the
present investigation, in which spectral analysis was af-
fected by different species, autonomic stimulation or block-
ade, blood pressure, and AR or FFT methodological ap-
proach, the present investigation strongly recommends
that studies or groups that intend to use spectral analysis
as a window to the autonomic nervous system use their
signal database of well-known experimental protocols with
autonomic nervous challenges to construct and share
some pairs of data and spectral “fingerprints” to compare
each new finding and conclusion within and between re-
search groups.
Experimental investigations (27) have suggested that
changes in autonomic balance might be helpful to identify
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high cardiovascular risk, i.e., life-threatening arrhythmias
during acute myocardial ischemia. Based on this experi-
mental evidence, in a prospective study, La Rovere et al.
(28) demonstrated that time- and frequency-domain indi-
ces of heart rate variability have independent prognostic
values after myocardial infarction. However, we are con-
cerned with the use of autonomic markers derived from
different spectral analysis methods to stratify cardiovascu-
lar risk. The dependence on the technique adopted and
the absence of agreement between AR and FFT spectral
analysis limit the direct application of these autonomic
markers in clinical practice. In fact, the present study and
others (21,22,24,25) have demonstrated that the AR and
FFT methods are not exactly interchangeable.
Taken together, the data obtained in the present study
demonstrate that the frequency-domain analysis, using
parametric (AR) or non-parametric (FFT) methods do not
agree in several aspects. The absence of agreement be-
tween methods extended to physiological conditions, i.e.,
postural changes in humans or pharmacological blockade
in experimental animals. The typical changes in the auto-
nomic markers observed during physiological conditions
were not equally detected by AR and FFT. Considering the
species studied, several differences were observed under
basal conditions in both human and rat models when AR
and FFT routines were applied for time- and frequency-
domain analysis. Under pathological conditions in pa-
tients, such as arterial hypertension, both methods seem
to be adequate for power spectral estimation and auto-
nomic index estimation. However, in a genetic model of
spontaneous hypertension (i.e., SHR) the parametric and
non-parametric methods evaluated were not concordant.
Furthermore, the present study showed that the disagree-
ment between parametric and non-parametric methods
was not restricted to the analysis of heart rate variability,
but affected equally the spectral analysis of systolic blood
pressure time series, and the overall disagreement be-
tween AR and FFT in this study was 43%.
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